What is Medroxyprogesterone?

Medroxyprogesterone is a prescription drug that is commonly used to treat hormonal imbalance disorders in women. It is a synthetic form of hormonal progesterone, which is involved in ovulation, menstruation and pregnancy. Oral medroxyprogesterone may be administered to treat absent periods, irregular bleeding or endometriosis. As a course of injection, the drug is also a highly effective contraceptive. There are risks of side effects and adverse drug interactions, so it is important to discuss health problems and the simultaneous use of medicines with a physician before receiving medroxyprogesterone.

During the menstrual cycle, the progesterone launches the uterine lining into separate and ovaries to relax. Women who experience irregular or absent periods, problems with spontaneous bleeding or unusual uterine cell growth often have too little progesterone in their systems. Medroxyprogesterone can supplement natural hormonal production to balance processes and promote reusionson. In addition, the very high level of synthetic progesterone in the body can prevent the ovaries from falling, preventing unwanted pregnancy.

The

tablets are supplied in five and 10 milligram sizes to be used exactly as prescribed by the prescribing physician. The amount of dosage is determined on the basis of weight, age, patient health and specific condition. Most adults are instructed to take one tablet a day for about 10 days or until the symptoms have decided. Patients taking a medicine such as contraception usually receive 150 milligrams injections every three months in a medical office for an indefinite period. The percentage during and after treatment and after treatment is important to ensure that complications do not arise.

The most common side effects in the use of medroxyprogesterone are nausea, stomach sickness, abdominal convulsions and temporarily severe menstrual bleeding. Some women experience aboutSpotity, insomnia, mild fever and high blood pressure. Drugs rarely can cause swelling and sensitivity in the growth of breasts, body and face and acne. Skin rashes and respiratory problems are a sign of allergic reactions and should be reported immediately by doctors.

There is a very slight risk of potentially serious blood clots after using medroxyprogesterone, especially if the patient smokes or uses blood pressure medicines. The doctor may reduce the risks by completing a thorough medical history before prescribing any new drugs. If the possibility of clotting is present, the patient may need to take a smaller dose or try another type of hormone regulatory drug. Most women who monitor the orders of their doctor and participate in scheduled inspections have no major problems.